Literature DB >> 15612986

MELD score versus conventional UNOS status in predicting short-term mortality after liver transplantation.

Gregorio Santori1, Enzo Andorno, Nicola Morelli, Adelmo Antonucci, Giuliano Bottino, Rosalia Mondello, Andrea Gianelli Castiglione, Roberto Valente, Ferruccio Ravazzoni, Stefano Di Domenico, Umberto Valente.   

Abstract

The Model for End-stage Liver Disease (MELD) provides a score able to predict short-term mortality in patients awaiting liver transplantation (LT). In the early 2002, United Network for Organ Sharing (UNOS) has proposed to replace the conventional statuses 3, 2B, and 2A with a modified MELD score. However, the accuracy of the MELD model to predict post-transplantation outcome is fairly elusive. In the present study we investigated the predictive value of the MELD score for short-term patient and graft mortality in comparison with conventional UNOS status. Sixty-nine patients listed at UNOS status 3 (n = 5), 2B (n = 55) or 2A (n = 9) who underwent LT were enrolled according to strict criteria. No donor-related parameters affected 3-month patient survival. Through univariate Cox regression, pretransplantation international normalized ratio (P = 0.049) and activated partial thromboplastin time (P = 0.032) were significantly associated with 3-month patient survival, although not in the subsequent multivariate analysis. The overall MELD score was 17 +/- 6.63 (median: 16, range: 4-34), increasing from UNOS Status 3 to 2A (r(2) = 0.171, P = 0.0001). No significant difference occurred in the median MELD score between patients who underwent a second LT and those who did not (P =0.458). The inter-rate agreement between UNOS status and MELD score after categorization for clinical urgency showed a fair agreement (kappa = 0.244). The 3-month patient and graft mortality was 15.94% and 20.29% respectively. The concordance statistic did not find significance between UNOS status and MELD score for 3-month patient (P = 0.283) or graft mortality (P = 0.957), although the MELD score revealed a major sensitivity for short-term patient mortality (0.637; 95%CI: 0.513-0.75). These findings suggest the need to implement MELD model accuracy for both inter-rate agreement with UNOS Status and patient outcome.

Entities:  

Mesh:

Year:  2005        PMID: 15612986     DOI: 10.1111/j.1432-2277.2004.00024.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  4 in total

1.  Short-term efficacy of treating hepatitis B virus-related acute-on-chronic liver failure based on cold pattern differentiation with hot herbs: A randomized controlled trial.

Authors:  Yu-Ming Guo; Feng-Yi Li; Man Gong; Lin Zhang; Jia-Bo Wang; Xiao-He Xiao; Jun Li; Yan-Ling Zhao; Li-Fu Wang; Xiao-Feng Zhang
Journal:  Chin J Integr Med       Date:  2016-05-24       Impact factor: 1.978

2.  Neurological complications after cadaveric and living donor liver transplantation.

Authors:  Fuat Saner; Yanli Gu; Shahin Minouchehr; Kavuk Ilker; Nils R Fruhauf; Andreas Paul; Arnold Radtke; Marc Dammann; Zaza Katsarava; Susanne Koeppen; Massimo Malagó; Christoph E Broelsch
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

3.  The risk factors associated with treatment-related mortality in 16,073 kidney transplantation-A nationwide cohort study.

Authors:  Hyunji Choi; Woonhyoung Lee; Ho Sup Lee; Seom Gim Kong; Da Jung Kim; Sangjin Lee; Haeun Oh; Ye Na Kim; Soyoung Ock; Taeyun Kim; Min-Jeong Park; Wonkeun Song; John Hoon Rim; Jong-Han Lee; Seri Jeong
Journal:  PLoS One       Date:  2020-07-28       Impact factor: 3.240

4.  Comparison of APACHE IV with APACHE II, SAPS 3, MELD, MELD-Na, and CTP scores in predicting mortality after liver transplantation.

Authors:  Hannah Lee; Susie Yoon; Seung-Young Oh; Jungho Shin; Jeongsoo Kim; Chul-Woo Jung; Ho Geol Ryu
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.